Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences
26 May 2022 - 10:00PM
Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”)
(Nasdaq: ADPT), a commercial stage biotechnology company that aims
to translate the genetics of the adaptive immune system into
clinical products to diagnose and treat disease, today announced it
will be participating in the following investor conferences.
- William Blair 42nd Annual Growth Stock Conference in Chicago,
ILPresenting on Wednesday, June 8th at 3:20 p.m. Central Time
- Goldman Sachs 43rd Annual Global Healthcare Conference in
Rancho Palos Verdes, CAPresenting on Wednesday, June 15th at 10:00
a.m. Pacific Time
Interested parties may access live and archived
webcasts of the sessions on the “Investors” section of the company
website at: www.adaptivebiotech.com.
About Adaptive Biotechnologies
Adaptive Biotechnologies (“we” or “our”) is a
commercial-stage biotechnology company focused on harnessing the
inherent biology of the adaptive immune system to transform the
diagnosis and treatment of disease. We believe the adaptive immune
system is nature’s most finely tuned diagnostic and therapeutic for
most diseases, but the inability to decode it has prevented the
medical community from fully leveraging its capabilities. Our
proprietary immune medicine platform reveals and translates the
massive genetics of the adaptive immune system with scale,
precision and speed to develop products in life sciences research,
clinical diagnostics and drug discovery. We have three commercial
products and a robust clinical pipeline to diagnose, monitor and
enable the treatment of diseases such as cancer, autoimmune
disorders, and infectious diseases. Our goal is to develop and
commercialize immune-driven clinical products tailored to each
individual patient.
ADAPTIVE INVESTORSKarina Calzadilla, Vice
President, Investor Relations201-396-1687Carrie Mendivil, Gilmartin
Groupinvestors@adaptivebiotech.com
ADAPTIVE MEDIALaura
Cooper205-908-5603media@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Mar 2024 to Mar 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Mar 2023 to Mar 2024